Literature DB >> 30747409

Substance Use Screening in HIV Care Settings: a Review and Critique of the Literature.

Anthony E Hitch1, Nicole K Gause2, Jennifer L Brown3.   

Abstract

PURPOSE OF REVIEW: People living with human immunodeficiency virus/AIDS (PLWHA) experience high prevalence of substance use disorders (SUD). HIV care settings represent a unique opportunity to identify possible SUD, to provide SUD interventions, and to improve linkage to SUD treatment. The aims of this paper are to (a) review and critique the extant literature examining substance use screening approaches among PLWHA in HIV care settings and (b) provide recommendations for future clinical practice. RECENT
FINDINGS: Twenty-one peer-reviewed articles that examined substance screening approaches employed in HIV and other primary care settings were included in the review. There was limited literature reporting on the implementation and evaluation of substance use screening practices within HIV care settings, and methodological rigor varied across studies. Further, the use of validated substance use screening measures or incorporation of other substance use screening approaches (e.g., use of urine drug testing) within routine HIV care practice is limited. Strategies to implement routine substance use screening within HIV care and incorporate additional substance use assessment, brief interventions, and referral to specialty substance use treatment are discussed. Use of self-report substance use screening measures using web- or computer-delivered approaches that can be integrated within electronic health record systems is particularly promising. HIV care practices should consider potential models to optimally screen and treat SUD. Co-location of HIV and SUD treatment services may be optimal; when co-located services are not possible, strategies to consistently provide brief intervention approaches and referrals to specialty SUD treatment are needed.

Entities:  

Keywords:  HIV/AIDS; Primary care; Screening; Screening, brief intervention, and referral to treatment (SBIRT); Substance use

Mesh:

Year:  2019        PMID: 30747409     DOI: 10.1007/s11904-019-00434-9

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  71 in total

1.  Mental disorders as risk factors for substance use, abuse and dependence: results from the 10-year follow-up of the National Comorbidity Survey.

Authors:  Joel Swendsen; Kevin P Conway; Louisa Degenhardt; Meyer Glantz; Robert Jin; Kathleen R Merikangas; Nancy Sampson; Ronald C Kessler
Journal:  Addiction       Date:  2010-03-10       Impact factor: 6.526

2.  HealthCall: technology-based extension of motivational interviewing to reduce non-injection drug use in HIV primary care patients - a pilot study.

Authors:  Efrat Aharonovich; Eliana Greenstein; Ann O'Leary; Barbara Johnston; Simone G Seol; Deborah S Hasin
Journal:  AIDS Care       Date:  2012-03-20

3.  Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City.

Authors:  Don C Des Jarlais; Kamyar Arasteh; Theresa Perlis; Holly Hagan; Abu Abdul-Quader; Douglas D Heckathorn; Courtney McKnight; Heidi Bramson; Chris Nemeth; Lucia V Torian; Samuel R Friedman
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

4.  Validity of the CRAFFT substance abuse screening test among adolescent clinic patients.

Authors:  John R Knight; Lon Sherritt; Lydia A Shrier; Sion Kim Harris; Grace Chang
Journal:  Arch Pediatr Adolesc Med       Date:  2002-06

5.  The drug abuse screening test.

Authors:  H A Skinner
Journal:  Addict Behav       Date:  1982       Impact factor: 3.913

6.  Validation of a brief screening instrument for substance abuse and mental illness in HIV-positive patients.

Authors:  Brian Wells Pence; Bradley N Gaynes; Kathryn Whetten; Joseph J Eron; Robert W Ryder; William C Miller
Journal:  J Acquir Immune Defic Syndr       Date:  2005-12-01       Impact factor: 3.731

7.  Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women.

Authors:  Judith A Cook; Jane K Burke-Miller; Mardge H Cohen; Robert L Cook; David Vlahov; Tracey E Wilson; Elizabeth T Golub; Rebecca M Schwartz; Andrea A Howard; Claudia Ponath; Michael W Plankey; Alexandra M Levine; Andrea Levine; Dennis D Grey
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

8.  Affect regulation, stimulant use, and viral load among HIV-positive persons on anti-retroviral therapy.

Authors:  Adam W Carrico; Mallory O Johnson; Judith T Moskowitz; Torsten B Neilands; Stephen F Morin; Edwin D Charlebois; Wayne T Steward; Robert H Remien; F Lennie Wong; Mary Jane Rotheram-Borus; Marguerita A Lightfoot; Margaret A Chesney
Journal:  Psychosom Med       Date:  2007-10-17       Impact factor: 4.312

9.  Continued Substance Use Among People Living With HIV-Hepatitis-C Co-Infection and Receiving Antiretroviral Therapy.

Authors:  Seth C Kalichman; Christopher Washington; Christopher Kegler; Tamar Grebler; Moira O Kalichman; Chauncey Cherry; Lisa Eaton
Journal:  Subst Use Misuse       Date:  2015-11-19       Impact factor: 2.164

10.  Considerations for the Development of a Substance-Related Care and Prevention Continuum Model.

Authors:  David C Perlman; Ashly E Jordan
Journal:  Front Public Health       Date:  2017-07-18
View more
  5 in total

1.  The Setting-Intervention Fit of Nine Evidence-Based Interventions for Substance Use Disorders Within HIV Service Organizations Across the United States: Results of a National Stakeholder-Engaged Real-Time Delphi Study.

Authors:  Bryan R Garner; Hannah K Knudsen; Brittany A Zulkiewicz; Stephen J Tueller; Heather J Gotham; Erika G Martin; Tom Donohoe; Alyssa K Toro; Katie Loyd; Theodore Gordon
Journal:  J Acquir Immune Defic Syndr       Date:  2022-07-01       Impact factor: 3.771

2.  The Patient Reported Outcomes as a Clinical Tool (PROACT) Pilot Study: What Can be Gained by Sharing Computerized Patient-Reported Mental Health and Substance Use Symptoms with Providers in HIV Care?

Authors:  Sarah M Jabour; Geetanjali Chander; Kristin A Riekert; Jeanne C Keruly; Kayla Herne; Heidi Hutton; Mary Catherine Beach; Bryan Lau; Richard D Moore; Anne K Monroe
Journal:  AIDS Behav       Date:  2021-02-09

3.  HIV care using differentiated service delivery during the COVID-19 pandemic: a nationwide cohort study in the US Department of Veterans Affairs.

Authors:  Kathleen A McGinnis; Melissa Skanderson; Amy C Justice; Kathleen M Akgün; Janet P Tate; Joseph T King; Christopher T Rentsch; Vincent C Marconi; Evelyn Hsieh; Christopher Ruser; Farah Kidwai-Khan; Roozbeh Yousefzadeh; Joseph Erdos; Lesley S Park
Journal:  J Int AIDS Soc       Date:  2021-10       Impact factor: 5.396

4.  Low-Burden Universal Substance Use Screening in a Primary Care Clinic to Lower Implementation Barriers.

Authors:  Deborah Konkle-Parker; Daniel Williams; Nicholas McAfee; Julie A Schumacher; Jefferson Parker
Journal:  J Behav Health Serv Res       Date:  2022-08-10       Impact factor: 1.475

5.  Substance use service availability in HIV treatment programs: Data from the global IeDEA consortium, 2014-2015 and 2017.

Authors:  Angela M Parcesepe; Kathryn Lancaster; E Jennifer Edelman; Raquel DeBoni; Jeremy Ross; Lukoye Atwoli; Mpho Tlali; Keri Althoff; Judicaël Tine; Stephany N Duda; C William Wester; Denis Nash
Journal:  PLoS One       Date:  2020-08-27       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.